Literature DB >> 21111013

Gene delivery with bisphosphonate-stabilized calcium phosphate nanoparticles.

Elisabeth V Giger1, Josep Puigmartí-Luis, Rahel Schlatter, Bastien Castagner, Petra S Dittrich, Jean-Christophe Leroux.   

Abstract

Nucleic acid drugs are promising new therapeutics, due to their possible applications in a wide variety of diseases and their strong targeting potential and associated lower off-target effects compared to conventional pharmaceuticals. However, their poor intracellular bioavailability and rapid degradation hinder their development as drugs. Therefore, efficient delivery is a major challenge. Various systems have been developed to overcome this problem. The entrapment of genetic material into nanoparticles constitutes a promising approach to increase the in vitro and in vivo transfection activity. Calcium phosphate-DNA co-precipitates have been used for gene delivery for more than 35 years and have the advantage of being nontoxic, easy to produce, and having the ability to complex nucleic acids leading to efficient transfection. Conventional synthetic methods yield particles that are only stable for a short period of time. Herein is proposed a versatile, surfactant-free method to stabilize calcium phosphate-DNA nanoparticles based on the use of poly(ethylene glycol)-functionalized bisphosphonate. The strength of the interaction between the bisphosphonate and the calcium phosphate enabled the formation of stable, but bioresorbable particles of around 200 nm, which exhibited physical stability over several days. Additionally, the nanoparticles revealed good and sustained ability to transfect cells while displaying low toxicity.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21111013     DOI: 10.1016/j.jconrel.2010.11.012

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  18 in total

1.  Inorganic nanovectors for nucleic acid delivery.

Authors:  Sandhya Pranatharthiharan; Mitesh D Patel; Anisha A D'Souza; Padma V Devarajan
Journal:  Drug Deliv Transl Res       Date:  2013-10       Impact factor: 4.617

2.  Turning an antiviral into an anticancer drug: nanoparticle delivery of acyclovir monophosphate.

Authors:  Jing Yao; Yuan Zhang; Srinivas Ramishetti; Yuhua Wang; Leaf Huang
Journal:  J Control Release       Date:  2013-06-18       Impact factor: 9.776

3.  Gene delivery using calcium phosphate nanoparticles: Optimization of the transfection process and the effects of citrate and poly(l-lysine) as additives.

Authors:  Mohammed A Khan; Victoria M Wu; Shreya Ghosh; Vuk Uskoković
Journal:  J Colloid Interface Sci       Date:  2016-03-05       Impact factor: 8.128

4.  In vivo gene delivery with L-tyrosine polyphosphate nanoparticles.

Authors:  Andrew J Ditto; John J Reho; Kush N Shah; Justin A Smolen; James H Holda; Rolando J Ramirez; Yang H Yun
Journal:  Mol Pharm       Date:  2013-04-08       Impact factor: 4.939

5.  Different inhibitory effect and mechanism of hydroxyapatite nanoparticles on normal cells and cancer cells in vitro and in vivo.

Authors:  Yingchao Han; Shipu Li; Xianying Cao; Lin Yuan; Youfa Wang; Yixia Yin; Tong Qiu; Honglian Dai; Xinyu Wang
Journal:  Sci Rep       Date:  2014-11-20       Impact factor: 4.379

Review 6.  Emerging strategies in reprogramming and enhancing the fate of mesenchymal stem cells for bone and cartilage tissue engineering.

Authors:  Yu Seon Kim; Antonios G Mikos
Journal:  J Control Release       Date:  2020-12-31       Impact factor: 9.776

7.  Bisphosphonates and cancer: what opportunities from nanotechnology?

Authors:  Giuseppe De Rosa; Gabriella Misso; Giuseppina Salzano; Michele Caraglia
Journal:  J Drug Deliv       Date:  2013-03-04

Review 8.  Calcium phosphate nanoparticles-based systems for siRNA delivery.

Authors:  Xiaochun Xu; Zehao Li; Xueqin Zhao; Lawrence Keen; Xiangdong Kong
Journal:  Regen Biomater       Date:  2016-03-04

Review 9.  Current and Future Theranostic Applications of the Lipid-Calcium-Phosphate Nanoparticle Platform.

Authors:  Andrew B Satterlee; Leaf Huang
Journal:  Theranostics       Date:  2016-04-27       Impact factor: 11.556

Review 10.  Bone site-specific delivery of siRNA.

Authors:  Xinli Liu
Journal:  J Biomed Res       Date:  2015-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.